Shandong Lukang Pharmaceutical Co Ltd (600789) — Cash Flow Reinvestment Rate
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Cash Flow Reinvestment Rate of 0.44x as of June 2025, reinvesting CN¥126.25 Million (capex CN¥88.93 Million plus investments CN¥-37.33 Million) from operating cash flow of CN¥285.47 Million. Check how high is Shandong Lukang Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Lukang Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. Explore long-term investment intensity of Shandong Lukang Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Shandong Lukang Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600789 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥340.05 Million | CN¥698.17 Million | CN¥338.86 Million | ▼ -63.5% |
| 2024 | 1.34x | CN¥538.05 Million | CN¥402.82 Million | CN¥279.18 Million | ▲ +14.0% |
| 2023 | 1.17x | CN¥707.69 Million | CN¥604.01 Million | CN¥337.91 Million | ▲ +17.2% |
| 2022 | 1.00x | CN¥444.18 Million | CN¥444.38 Million | CN¥428.36 Million | ▼ -71.8% |
| 2021 | 3.54x | CN¥528.93 Million | CN¥149.33 Million | CN¥486.75 Million | ▲ +11.0% |
| 2020 | 3.19x | CN¥748.51 Million | CN¥234.55 Million | CN¥703.12 Million | ▲ +6.1% |
| 2019 | 3.01x | CN¥1.09 Billion | CN¥361.87 Million | CN¥828.61 Million | ▼ -10.7% |
| 2018 | 3.37x | CN¥1.18 Billion | CN¥351.09 Million | CN¥855.24 Million | ▼ -16.3% |
| 2017 | 4.02x | CN¥1.11 Billion | CN¥275.51 Million | CN¥780.71 Million | ▲ +70.4% |
| 2016 | 2.36x | CN¥699.51 Million | CN¥296.23 Million | CN¥371.51 Million | ▼ -71.6% |
| 2015 | 8.31x | CN¥651.58 Million | CN¥78.39 Million | CN¥164.54 Million | ▲ +665.1% |
| 2014 | 1.09x | CN¥117.94 Million | CN¥108.56 Million | CN¥117.94 Million | ▲ +21.0% |
| 2013 | 0.90x | CN¥230.35 Million | CN¥256.50 Million | CN¥230.35 Million | ▼ -63.6% |
| 2012 | 2.47x | CN¥284.40 Million | CN¥115.20 Million | CN¥284.40 Million | ▼ -29.0% |
| 2011 | 3.48x | CN¥428.82 Million | CN¥123.28 Million | CN¥428.82 Million | ▲ +269.6% |
| 2010 | 0.94x | CN¥290.69 Million | CN¥308.88 Million | CN¥290.69 Million | ▲ +169.9% |
| 2009 | 0.35x | CN¥69.57 Million | CN¥199.49 Million | CN¥69.57 Million | ▼ -4.7% |
| 2008 | 0.37x | CN¥76.58 Million | CN¥209.39 Million | CN¥76.58 Million | ▲ +116.0% |
| 2007 | 0.17x | CN¥23.25 Million | CN¥137.30 Million | CN¥23.25 Million | ▼ -56.9% |
| 2006 | 0.39x | CN¥22.12 Million | CN¥56.24 Million | CN¥22.12 Million | ▲ +3.7% |
| 2005 | 0.38x | CN¥61.27 Million | CN¥161.64 Million | CN¥61.27 Million | ▼ -82.0% |
| 2004 | 2.10x | CN¥133.10 Million | CN¥63.24 Million | CN¥133.10 Million | ▲ +96.6% |
| 2003 | 1.07x | CN¥179.25 Million | CN¥167.42 Million | CN¥179.25 Million | ▲ +69.0% |
| 2002 | 0.63x | CN¥199.94 Million | CN¥315.59 Million | CN¥199.94 Million | ▼ -15.8% |
| 2001 | 0.75x | CN¥203.50 Million | CN¥270.43 Million | CN¥203.50 Million | ▼ -93.3% |
| 2000 | 11.21x | CN¥250.64 Million | CN¥22.36 Million | CN¥250.64 Million | ▲ +312.0% |
| 1999 | 2.72x | CN¥95.56 Million | CN¥35.12 Million | CN¥95.56 Million | ▼ -20.0% |
| 1998 | 3.40x | CN¥156.96 Million | CN¥46.18 Million | CN¥156.96 Million | — |